Achieve recently announced that the FDA accepted its cytisinicline New Drug Application for treatment of nicotine dependence for smoking cessation, with a PDUFA target action date of June 20, 2026.
Some reviews in the analysis also noted a higher chance of young people who vape turning to marijuana, alcohol, and stimulant ...
Effective public health, financial aid, and regulatory interventions have proven benefits against disease and death. But many countries, not just the US, seem to be reversing their course—deliberately ...
With nicotine use among young adults rising, local public health advocates are still working to encourage similar bans at ...
Detailed price information for Achieve Life Sciences Inc (ACHV-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback